Osborne Partners Capital Management LLC lessened its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 5.6% in the 1st quarter, Holdings Channel reports. The firm owned 170,839 shares of the exchange traded fund’s stock after selling 10,125 shares during the period. SPDR S&P Biotech ETF makes up 1.2% of Osborne Partners Capital Management LLC’s investment portfolio, making the stock its 23rd largest holding. Osborne Partners Capital Management LLC’s holdings in SPDR S&P Biotech ETF were worth $21,821,000 as of its most recent SEC filing.
A number of other institutional investors have also recently made changes to their positions in XBI. Baer Investment Advisory LLC purchased a new position in SPDR S&P Biotech ETF in the first quarter worth about $229,000. Turtle Creek Wealth Advisors LLC purchased a new stake in SPDR S&P Biotech ETF during the first quarter valued at approximately $160,000. Marotta Asset Management raised its position in SPDR S&P Biotech ETF by 0.8% during the first quarter. Marotta Asset Management now owns 66,108 shares of the exchange traded fund’s stock valued at $8,498,000 after purchasing an additional 550 shares during the period. Y Intercept Hong Kong Ltd bought a new stake in shares of SPDR S&P Biotech ETF in the 1st quarter valued at approximately $862,000. Finally, Trademark Financial Management LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 1st quarter valued at approximately $287,000.
SPDR S&P Biotech ETF Stock Performance
Shares of SPDR S&P Biotech ETF stock opened at $160.46 on Friday. The stock has a market cap of $11.09 billion, a price-to-earnings ratio of 11.47 and a beta of 0.81. The stock has a 50 day moving average price of $137.41 and a 200-day moving average price of $129.96. SPDR S&P Biotech ETF has a one year low of $83.02 and a one year high of $160.82.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Recommended Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
